Journals / Türk Kardiyoloji Derneği Arşivi / 2013 / Cilt: 41 - Sayı: 7

Relation of heart-type fatty acid-binding protein with the degree and extent of atherosclerosis in patients with non-ST elevation acute coronary syndrome

ST segment yükselmesiz akut koroner sendromlu hastalarda kalp tipi yağ asidi bağlayıcı proteinin koroner arter hastalığının yaygınlık ve ciddiyeti ile ilişkisi

Pages
610–616
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The duration of chest pain in the H-FABP-positive group was significantly longer than in the negative group (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: The relationship between markers of myocardial ischemia and severity of coronary artery disease (CAD) has been investigated in several studies.
📊
Key Findings & Data:Study design: This prospective study comprised 49 pa- tients who were referred to the emergency room with a diag- nosis of non-ST elevation myocardial infarction.
💡
Conclusion & Impact:The duration of chest pain in the H-FABP-positive group was significantly longer than in the negative group (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objectives: The relationship between markers of myocardial ischemia and severity of coronary artery disease (CAD) has been investigated in several studies. In this study, we exam- ined the relationship between severity of CAD and heart-type fatty acid-binding protein (H-FABP), a new marker of ischemia in patients with non-ST-segment elevation acute coronary syn- drome (ACS). Study design: This prospective study comprised 49 pa- tients who were referred to the emergency room with a diag- nosis of non-ST elevation myocardial infarction. Troponins, creatine kinase-MB, lactate dehydrogenase, and aspartate aminotransferase levels were measured quantitatively, while blood H-FABP levels were measured qualitatively in the 4th- 8th hour from the onset of symptoms. All patients underwent coronary angiography within 72 hours after admission. Clini- cal and coronary angiographic characteristics of patients with positive and negative values of H-FABP were compared. Gensini and SYNTAX scores were used to determine the se- verity of CAD. Results: There were no statistically significant differences in mean age, gender distribution, risk factors for CAD, ischemic changes on ECG, or Gensini and SYNTAX scores between the H-FABP-negative and -positive groups (p>0.05). The duration of chest pain in the H-FABP-positive group was significantly longer than in the negative group (p

Özet

Amaç: Miyokart iskemisi belirteçleri ile koroner arter hastalığı ciddiyetinin ilişkisi birçok çalışmada araştırılmıştır. Bu çalışmada, ST segment yükselmesiz akut koroner sendromlu (AKS) hastalarda yeni bir iskemi belirteci olan kalp tipi yağ asidi bağlayıcı protein (KYABP) ile koroner arter hastalığı (KAH) ciddiyetinin ilişkisi incelendi.Çalışma planı: Çalışma ileriye dönük ve kesitsel olarak tasarlandı. Çalışmaya acil servise başvuran ST segment yükselmesiz AKS tanısı konan 49 hasta alındı. Semptom başlangıcının 4.-8. saat aralığında alınan kan örneğinden KYABP kalitatif olarak; troponin, kreatin kinaz-MB, laktat dehidrogenaz ve aspartat aminotransferaz düzeyleri kantitatif olarak ölçüldü. Tüm hastalara başvurudan sonraki ilk 72 saat içinde koroner anjiyografi yapıldı. KYABP pozitif ve negatif hastaların demografik özellikleri ve biyokimyasal değerleri, TİMİ risk skoru ve koroner anjiyografi özellikleri karşılaştırıldı. KAH ciddiyeti Gensini ve SYNTAX skorlaması ile değerlendirildi.Bulgular: KYABP negatif grup ile pozitif grup arasında yaş ortalamaları, cinsiyet dağılımı, eşlik eden KAH risk faktörleri ve iskemik EKG değişikliği yönünden istatistiksel anlamlı farklılık görülmedi (p>0.05). Göğüs ağrısı süresi KYABP pozitif olan grupta negatif gruptakinden anlamlı olarak daha yüksek bulundu (p0.05). TİMİ risk skoru KYABP pozitif grupta anlamlı olarak yüksek bulundu (p

🔖

Cite This Article

ŞAHİN, O., GÜNAYDIN, Z. Y., KIRIŞ, T., KÖPRÜLÜ, D., ZEREN, G., AKSU, H., ERER, H. B., ERDOĞAN, G., SAYAR, N., EREN, M., GÜVENÇ, T. S. (2022). Relation of heart-type fatty acid-binding protein with the degree and extent of atherosclerosis in patients with non-ST elevation acute coronary syndrome. Türk Kardiyoloji Derneği Arşivi, Cilt: 41 - Sayı: 7, 610–616. https://ajindex.com/articles/632929

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Karmen A, Wroblewski F, Ladue JS. Transaminase activity in human blood. J Clin Invest 1955;34:126-31
  2. Sabatine MS, Morrow DA, de Lemos JA, Gibson CM, Murphy SA, Rifai N, et al. Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide. Circulation 2002;105:1760-3
  3. Hamm CW, Katus HA. New biochemical markers for myocardial cell injury. Curr Opin Cardiol 1995;10:355-60
  4. Thygesen K, Alpert JS, White HD; Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction, Jaffe AS, Apple FS, Galvani M, et al. Universal definition of myocardial infarction. Circulation 2007;116:2634-53
  5. Glatz JF, van Bilsen M, Paulussen RJ, Veerkamp JH, van der Vusse GJ, Reneman RS. Et al. Release of fatty acid-binding protein from isolated rat heart subjected to ischemia and reperfusion or to the calcium paradox. Biochim Biophys Acta 1988;961:148-52
  6. Offner GD, Brecher P, Sawlivich WB, Costello CE, Troxler RF. Characterization and amino acid sequence of a fatty acid-binding protein from human heart. Biochem J 1988;252:191-8
  7. Glatz JF, van der Vusse GJ, Simoons ML, Kragten JA, van Dieijen-Visser MP, Hermens WT. Fatty acid-binding protein and the early detection of acute myocardial infarction. Clin Chim Acta 1998;272:87-92
  8. Ishii J, Ozaki Y, Lu J, Kitagawa F, Kuno T, Nakano T, et al. Prognostic value of serum concentration of heart-type fatty acid-binding protein relative to cardiac troponin T on admission in the early hours of acute coronary syndrome. Clin Chem 2005;51:1397-404
  9. Lagerqvist B, Diderholm E, Lindahl B, Husted S, Kontny F, Ståhle E, et al. FRISC score for selection of patients for an early invasive treatment strategy in unstable coronary artery disease. Heart 2005;91:1047-52
  10. Boersma E, Pieper KS, Steyerberg EW, Wilcox RG, Chang WC, Lee KL, et al. Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. The PURSUIT Investigators. Circulation 2000;101:2557-67
  11. Antman EM, Cohen M, Bernink PJ, McCabe CH, Horacek T, Papuchis G, et al. The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making. JAMA 2000;284:835-42
  12. Granger CB, Goldberg RJ, Dabbous O, Pieper KS, Eagle KA, Cannon CP, et al. Predictors of hospital mortality in the global regi